Total Payments
$1,391
2024 Payments
$418.21
Companies
24
Transactions
67
Medicare Patients
25,073
Medicare Billing
$5.2M
Payment Breakdown by Category
Food & Beverage$1,268 (91.2%)
Education$122.97 (8.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,268 | 63 | 91.2% |
| Education | $122.97 | 4 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $380.20 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $145.07 | 6 | $0 (2024) |
| Celgene Corporation | $138.92 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $108.78 | 5 | $0 (2024) |
| Amgen Inc. | $82.65 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $68.84 | 6 | $0 (2024) |
| Incyte Corporation | $51.43 | 3 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $48.96 | 2 | $0 (2023) |
| BIOPROTECT MEDICAL, INC. | $45.51 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $38.63 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $418.21 | 18 | Janssen Biotech, Inc. ($67.06) |
| 2023 | $188.98 | 9 | Daiichi Sankyo Inc. ($44.57) |
| 2022 | $67.01 | 3 | GENZYME CORPORATION ($28.62) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $208.37 | 7 | Janssen Biotech, Inc. ($168.10) |
| 2019 | $144.58 | 7 | Janssen Biotech, Inc. ($77.56) |
| 2018 | $178.99 | 12 | Janssen Biotech, Inc. ($36.70) |
| 2017 | $173.14 | 10 | Novartis Pharmaceuticals Corporation ($62.29) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 12/10/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $45.51 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), DARZALEX, TALVEY | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Oncology | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Immunology | ||||||
| 07/31/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 05/21/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $35.03 | General |
| Category: Hematology | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Oncology | ||||||
| 03/18/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $29.31 | General |
| 12/13/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Oncology | ||||||
| 10/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 06/23/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/05/2023 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 67 | 4,055 | 54,017 | $4.7M | $1.1M |
| 2022 | 70 | 4,598 | 89,251 | $5.9M | $1.4M |
| 2021 | 87 | 7,404 | 108,180 | $6.6M | $1.5M |
| 2020 | 87 | 9,016 | 87,913 | $5.8M | $1.2M |
Total Patients
25,073
Total Services
339,361
Medicare Billing
$5.2M
Procedure Codes
311
All Medicare Procedures & Services
311 procedure records from CMS Medicare Utilization — Page 13 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 22 | 23 | $1,104 | $193.22 | 17.5% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2020 | 35 | 640 | $16,000 | $144.54 | 0.9% |
| 84100 | Phosphate level | Office | 2020 | 23 | 30 | $690.00 | $141.12 | 20.5% |
| 82248 | Bilirubin level | Office | 2020 | 12 | 15 | $330.00 | $74.90 | 22.7% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2020 | 15 | 15 | $315.00 | $56.84 | 18.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 49 | 91 | $454.00 | $55.56 | 12.2% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 22 | 27 | $513.00 | $53.07 | 10.3% |
| J3490 | Unclassified drugs | Office | 2020 | 45 | 79 | $711.00 | $51.24 | 7.2% |
| 81002 | Urinalysis, manual test | Office | 2020 | 11 | 14 | $210.00 | $48.58 | 23.1% |
| 84155 | Total protein level, blood | Office | 2020 | 11 | 12 | $492.00 | $40.49 | 8.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 12 | 20 | $380.00 | $31.12 | 8.2% |
About Dr. Gregory Orloff, M.D
Dr. Gregory Orloff, M.D is a Hematology & Oncology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750358776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Orloff, M.D has received a total of $1,391 in payments from pharmaceutical and medical device companies, with $418.21 received in 2024. These payments were reported across 67 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,268).
As a Medicare-enrolled provider, Orloff has provided services to 25,073 Medicare beneficiaries, totaling 339,361 services with total Medicare billing of $5.2M. Data is available for 4 years (2020–2023), covering 311 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Fairfax, VA
- Active Since 03/08/2006
- Last Updated 10/24/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1750358776
Products in Payments
- DARZALEX (Biological) $145.05
- ERLEADA (Drug) $143.82
- KEYTRUDA (Biological) $63.16
- INJECTAFER (Drug) $59.13
- REBLOZYL (Biological) $55.54
- JAKAFI (Drug) $51.43
- Enhertu (Drug) $49.65
- KYMRIAH (Biological) $48.89
- IMBRUVICA (Drug) $45.74
- BIOPROTECT BALLOON IMPLANT SYSTEM (Device) $45.51
- OPDIVO (Biological) $38.63
- TAGRISSO (Drug) $38.48
- JEVTANA (Drug) $28.62
- Fabhalta (Drug) $25.20
- Kyprolis (Drug) $25.05
- KISQALI (Drug) $23.76
- TECVAYLI (Biological) $23.46
- Tibsovo (Drug) $23.44
- TALVEY (Biological) $23.10
- Aranesp (Biological) $22.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Fairfax
Dr. William Ershler, M.d, M.D
Hematology & Oncology — Payments: $143,157
Hematology & Oncology $143,157
Nagla Abdel Karim, Md, MD
Hematology & Oncology — Payments: $126,207
Hematology & Oncology $126,207
Dipti Patel-Donnelly, M.d, M.D
Hematology & Oncology — Payments: $46,716
Hematology & Oncology $46,716
Nicholas Robert, M.d, M.D
Hematology & Oncology — Payments: $34,071
Hematology & Oncology $34,071
Daniel Chong, M.d, M.D
Hematology & Oncology — Payments: $19,434
Hematology & Oncology $19,434
Timothy Mccarthy, M.d, M.D
Hematology & Oncology — Payments: $7,653
Hematology & Oncology $7,653